Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of s… https://t.co/kYyOAY6MOf
    about 10 hours ago
  • New post on Science and Enterprise: NIH Funds Programmable mRNA to Treat Cancer https://t.co/DKptaY956d #Science #Business
    about 10 hours ago
  • Attn @ArcticFisheries .. Why Migraine Sufferers May Want to Eat More Fish https://t.co/3AaUvjuNqT
    about 14 hours ago
  • Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and ther… https://t.co/iJUJA00PmY
    about 1 day ago
  • New post on Science and Enterprise: Sanofi Acquires mRNA Developer in $3.2B Deal https://t.co/lRVt9pv3bq #Science #Business
    about 1 day ago

Please share Science & Enterprise

ALS Drug Maker Gains $135M in New Funds

Man in wheelchair

A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round. . . . → Read More: ALS Drug Maker Gains $135M in New Funds

Pooled Saliva Tests Detect Covid-19 in Schools

Preparing classrooms for students return

Combining commercial saliva tests to speed detection of the SARS-CoV-2 virus in schools is shown as accurate as individual gold-standard nasal swab tests. . . . → Read More: Pooled Saliva Tests Detect Covid-19 in Schools

Trial to Test Antibody Drug for Alzheimer’s Prevention

Neurons

Eli Lilly and Company is partnering with an Alzheimer’s disease research center to test a synthetic antibody for preventing the disorder in at-risk individuals. . . . → Read More: Trial to Test Antibody Drug for Alzheimer’s Prevention

$60M Challenge Seeks RNA Bio-Production Network

Gene therapy graphic

A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products. . . . → Read More: $60M Challenge Seeks RNA Bio-Production Network

Precision Gene-Editing Biotech Gains $200M in New Funds

David Liu

A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections. . . . → Read More: Precision Gene-Editing Biotech Gains $200M in New Funds

Trial Underway for Crispr Lymphoma Therapy

Crispr-Cas9

A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr. . . . → Read More: Trial Underway for Crispr Lymphoma Therapy

Neuro Disease Start-Up Raises $73M in Early Funds

Nerve cells illustration

A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds

Fitness Tracker Data Show Longer Covid-19 Effects

Apple Watch and iPhone

Data collected from wearable activity trackers show extended cardiac effects in people with Covid-19 infections, in some cases for several months. . . . → Read More: Fitness Tracker Data Show Longer Covid-19 Effects

Univ. Lab Testing Wearable Respiratory Monitor

ADAMM device

Medical researchers are assessing the feasibility of a wearable device to detect advance indicators of chronic respiratory disease symptoms. . . . → Read More: Univ. Lab Testing Wearable Respiratory Monitor

Trial Underway Testing Suicide-Prevention Nasal Spray

Sad, depressed

A clinical trial testing a nasal spray against a placebo to prevent suicide from depression enrolled its first participants considered at high risk of suicide. . . . → Read More: Trial Underway Testing Suicide-Prevention Nasal Spray